PORTLAND, Ore. & SEATTLE--(BUSINESS WIRE)--Dec. 18, 2002--AVI BioPharma, Inc., today announced a research agreement with privately held International Therapeutics, Inc. (ITI), to develop AVI s proprietary NEUGENE(R) antisense compounds as novel therapeutics for HIV. As part of the agreement, ITI will collaborate in
SACRAMENTO, Calif.--(BUSINESS WIRE)--Dec. 17, 2002-- The mammoth CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (CalPERS) -- which is estimated to hold nearly $1 billion in GLAXOSMITHKLINE (GSK) shares -- yesterday vowed to investigate the impact GSK s drug pricing policies on retirees, the state and people in need of A
FOSTER CITY, Calif.--(BUSINESS WIRE)--Dec. 17, 2002-- Gilead Sciences announced today that the company is developing the Viread Access Program to provide Viread(R) (tenofovir disoproxil fumarate), the company s once-a-day antiretroviral medication for HIV, at no profit in every country in Africa and i
NEW YORK--(BUSINESS WIRE)--Dec. 13, 2002--For the second consecutive year, the American Foundation for AIDS Research (amfAR) was named one of America s 100 Best Charities by Worth magazine. There are over 850,000 nonprofits in the United States ,and amfAR was one of only 13 national health organizations that Worth ulti
ALAMEDA, Calif.--(BUSINESS WIRE)--Dec. 13, 2002-- Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, announced today that it has executed a Memorandum of Understanding (MOU) with the Safe Blood for Africa Foundatio
ALAMEDA, Calif.--(BUSINESS WIRE)--Dec. 10, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot supplemental test, today announced that Community Hea
HOUSTON--(BUSINESS WIRE)--Dec. 2, 2002--Researched by Industrialinfo.com (Industrial Information Resources Incorporated; Houston). Although a relatively new disease, HIV/AIDS has rapidly become one of the world s top healthcare priorities over the past two decades. Approximately 60 million individuals have been infecte
WASHINGTON--(BUSINESS WIRE)--Nov. 25, 2002--In one of the largest studies ever conducted of the spermicide nonoxynol-9 (N-9), it was demonstrated that N-9 in film form and marketed under the name of VCF(R) Vaginal Contraceptive Film(TM) does not increase the transmission of the AIDS virus. Over one thousand women, most
ALAMEDA, Calif.--(BUSINESS WIRE)--Nov. 25, 2002--Calypte Biomedical Corporation, the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot supplemental test, today provided an update on recent new product
NEW YORK--(BUSINESS WIRE)--Nov. 21, 2002-- Innovative Technology Acquisition Corporation (OTCBB:ITAQ) announces that Stephen Leibtag has been named President of BioSource Therapeutics, Inc., (BST) a wholly-owned subsidiary of Innovative Technology Acquisition Corporation. Mr. Leibtag will also serve as a member of the
PASADENA, Calif.--(BUSINESS WIRE)--Nov. 21, 2002--Kaiser Permanente has awarded community service grants totaling $352,500 to 74 agencies throughout California that provide special services to people who are HIV-positive or have acquired immune deficiency syndrome (AIDS). The grants support nonprofit agencies that prov
EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 21, 2002--Medical Services International Inc. (Pink Sheets: MSITF) is pleased to announce that it has agreed with the regulatory authorities of a West African Nation to a study involving 200 VScan(TM) Rapid HIV Test Kits. The study is to start in 60 days with results in 90 days.
NEW YORK--(BUSINESS WIRE)--Nov. 20, 2002-- The nation s only museum dedicated to the art of the comic book, The New York City Comic Book Museum (NYCCBM), is partnering with Cable Positive, the cable and telecommunications industry s national non-profit AIDS action organization, to sponsor Comic Books Fight AIDS, a Worl
TAMPA, Fla.--(BUSINESS WIRE)--Nov. 20, 2002--eLogic Learning, a next generation provider of fully-integrated, end-to-end eLearning solutions, today announced that it has been selected to provide Population Services International ( PSI ) with the learning technology behind their recently initiated Health Portal Program.
EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 19, 2002--Medical Services International Inc. is pleased to announce the independent test results on the VScan(TM) HIV Rapid Test Kits sent to Nigeria . As part of the registration process in Nigeria, the Company was required to send VScan(TM) Rapid Test Kits to the Mainland Hos
EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 18, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it has finalized the distribution agreement announced on Oct. 23, 2002, with Minerva Baltika appointing them as the company s exclusive distributor for the VScan(TM) Rapid Test Kit in t
PHILADELPHIA--(BUSINESS WIRE)--Nov. 12, 2002--Driven largely by the HIV/AIDS epidemic, the past decade has seen major changes in the use of blood transfusion. The September/October issue of American Journal of Therapeutics is a special thematic issue presenting expert commentaries on the most important areas affecting
TORONTO--(BUSINESS WIRE)--Nov. 11, 2002--HIV-VAC INC. (the Company ) announces that it filed a Form S-8 Registration Statement with the SEC in connection with the issuance of an aggregate of 1,150,000 common shares on October 30, 2002. The shares were issued to a total of four consultants who each provided business con
PHOENIX--(BUSINESS WIRE)--Nov. 8, 2002--The City of Phoenix has awarded Southwest Behavioral Health (SBH), www.sbhservices.org, four housing sites, which collectively can accommodate up to 18 individuals with HIV/AIDS. SBH will take possession of the sites later this month. According to SBH s Cheryl Cuyler, vice presid
BETHLEHEM, Pa.--(BUSINESS WIRE)--Nov. 7, 2002--OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that it has received approval from the U.S. Food and Drug Administration ( FDA ) for its OraQuick(R) Rapid HIV-1 Antibody Test. Pursuant to this approval, the Company can
NEW YORK--(BUSINESS WIRE)--Nov. 6, 2002-- Innovative Technology Acquisition Corporation (OTCBB:ITAQ) has acquired 100 percent of BioSource Therapeutics, Inc. (BST), a life science biotechnology corporation dedicated to the research and development of innovative dietary supplements that address the effects of epidemic v
SEATTLE--(BUSINESS WIRE)--Nov. 5, 2002--International Therapeutics, Inc. (ITI) announces the selection of Seattle Biomedical Research Institute (SBRI) as the recipient of the annual Glenn Kawasaki Humanitarian Award. The $10,000 award recognizes individuals or institutions for accomplishments in the social, scientific,
LA JOLLA, Calif.--(BUSINESS WIRE)--Oct. 31, 2002--Aethlon Medical Inc. (OTCBB:AEMD) announced today that it has significantly improved the rate of removing HIV toxic viral proteins from HIV infected blood. HIV produces copious amounts of toxic surface proteins known as gp120. Gp120 damages nerve cells and white blood c
SAN MATEO, Calif.--(BUSINESS WIRE)--Oct. 31, 2002--SciClone Pharmaceuticals, Inc. (Nasdaq:SCLN) today reported that ZADAXIN(R), in addition to previously observed immunological effects, for the first time has shown direct antiviral effects on cells infected with the hepatitis B virus (HBV) and human
BETHLEHEM, Pa.--(BUSINESS WIRE)--Oct. 23, 2002--OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that the Company was selected by the United States Department of Commerce to join a business development mission to Ghana and
EAST HILLS, N.Y.--(BUSINESS WIRE)--Oct. 23, 2002--Pall Corporation announced today that the U.S. Food and Drug Administration ( FDA ) granted clearance to market the Pall(R) BDS, a new system to detect bacterial contamination of platelets. Bacterial contamination of platelets is the leading cause of morbidity and morta
SEATTLE--(BUSINESS WIRE)--Oct. 17, 2002--International Therapeutics, Inc. announced today that it has entered into a Collaborative Research Agreement with City of Hope National Medical Center and Beckman Research Institute (Duarte, CA), to evaluate and characterize novel small interfering RNA (siRNA) molecules against
NEW DELHI, India--(BUSINESS WIRE)--Oct. 16, 2002--Ranbaxy SA (Pty), a wholly owned subsidiary of Ranbaxy Laboratories Limited (Ranbaxy) and Tiger Brands Healthcare division, Adcock Ingram, today announced the formation of a 50:50 joint venture to exclusively sell and distribute Ranbaxy s range of anti-retroviral produc
EDMONTON, Albert--(BUSINESS WIRE)--Oct. 16, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it has began to ship VScan(TM) HIV Rapid Test Kit samples to the Baltics to begin initial product evaluation and testing. The Baltics is an area where we have previously not had any invo
SAN DIEGO--(BUSINESS WIRE)--Oct. 15, 2002--The Food and Drug Administration should protect healthcare workers by banning the use of suture for securing catheters, Venetec International asserts in documents recently filed with the FDA . Doctors and nurses who secure catheters with suture needles are unnecessarily expose
ALAMEDA, Calif.--(BUSINESS WIRE)--Oct. 15, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced that it has received its first commercial order from its new Chinese distributor for the Urine HIV-1 EIA. Calyp
AUSTIN, Texas--(BUSINESS WIRE)--Oct. 11, 2002-- On Sept. 6, the Texas Department of Health (TDH) issued its funding decisions for HIV/AIDS prevention for the next five years. Rally for Our Lives When: Saturday, Oct. 19, 2002 Time: 4-7 p.m. Where: Texas State Capitol Building (south steps) In these decisions, TDH chose
NEW YORK--(BUSINESS WIRE)--Oct. 11, 2002--Innovative Technology Acquisition Corporation (OTCBB:ITAQ) has entered into an agreement to acquire 100 percent of BioSource Therapeutics, Inc. (BST), a life science biotechnology corporation dedicated to the research and development of innovative dietary supplements that addre
EDMONTON, Alberta--(BUSINESS WIRE)--Oct. 9, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that its VScan(TM) HIV (Serum) Rapid Test Kit identifies the new strain of HIV (subgroup O) that is now showing up in North America. All previous testing has shown that the VScan(TM) Test Kit
ALAMEDA, Calif.--(BUSINESS WIRE)--Oct. 9, 2002--Calypte Biomedical Corporation (OTCBB:CALY) the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, today announced that it held a preliminary Investigational Device Exemption (pre-IDE) meeting with the Food and Drug
SAN FRANCISCO--(BUSINESS WIRE)--Oct. 7, 2002-- Levi s(R) Jeans today announced the launch of a fundraising and awareness campaign to benefit Population Services International s (PSI) YouthAIDS program. The campaign, part of Levi s Jeans ongoing 20-year commitment to the fight against HIV/AIDS, includes two one-of-a-kin
MONTREAL--(BUSINESS WIRE)--Oct. 7, 2002--Franc-Or Resources Corporation (TSX:FOR) is pleased to announce that the US Food and Drug Administration ( FDA ) has granted approval of Urrma Biopharma Inc. s Investigational Device Exemption (IDE) application for the Anti-R7V Diagnostic Kit. This is equivalent to a Phase Two a
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Oct. 7, 2002--Amerimmune Pharmaceuticals, Inc. (OTCBB:AMUN), announced that it has filed a patent application to protect the company s intellectual property for an investigational monoclonal antibody to treat patients suffering from human immunodeficiency virus (HIV) and Acqui
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Oct. 1, 2002--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced the development of vaccine candidates that contain critical surface proteins whose form closely mimics the structures found on the virus. Until now, the instability of these surface spikes has hampered efforts to pr
SAN DIEGO--(BUSINESS WIRE)--Sept. 27, 2002--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) reported positive findings from a completed Phase II clinical trial of its investigational HIV entry inhibitor, PRO 542. Single doses of PRO 542 reduced concentrations of the human immunodeficiency (HIV) in the blood by 60% to 80
WASHINGTON--(BUSINESS WIRE)--Sept. 26, 2002--A broad-based coalition of over 85 leading scientists and health groups today issued a statement calling upon manufacturers of condoms and lubricants to voluntarily remove Nonoxyonol-9 (N-9) from their products. N-9 is the active ingredient in all over-the-counter contracept
HYDERABAD, India--(BUSINESS WIRE)--Sept. 26, 2002--Dr. Reddy s Laboratories Ltd. (NYSE:RDY) will present as many as 10 posters on its anti-infective discovery program at the 42nd annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at San Diego, California, USA, from September 27-3
Good medical news for millions of Americans searching for simpler ways to treat HIV, diabetes, heart disease and other chronic illnesses. Instead of juggling countless medications with complicated requirements, new once-a-day-dosing therapies may be just what the doctor ordered. Get video here. You can reach the story
MIAMI LAKES, Fla.--(BUSINESS WIRE)--Sept. 20, 2002--World Diagnostics, Inc. (OTCBB:WDGI), www.worlddiagnostics.com, a pioneering global provider of medical diagnostic tests and specialized laboratory products for the international marketplace, announced today that it will begin shipments of its Smart Check HIV rapid te
LOS ANGELES--(BUSINESS WIRE)--Sept. 18, 2002--AIDS Project Los Angeles (APLA) and Minority AIDS Project (MAP) are the co-chairs of the Sept. 19 California Host Committee Day-Long Institute at the U.S. Conference on AIDS 2002 (USCA), taking place Sept. 19-22 in Anaheim, Calif. To coincide with the national conference, A
LOS ANGELES--(BUSINESS WIRE)--Sept. 17, 2002--AIDS Healthcare Foundation: -- Governor Davis Signed Landmark Bill (AB 2168) in September 2000 Mandating HMOs Provide Standing Referrals to AIDS Specialists for HIV Positive Members. AHF Efforts Lead to Additional State Regulations Soon Taking Effect As new regulations supp
LOS ANGELES--(BUSINESS WIRE)--Sept. 6, 2002--The United States largest AIDS organization described yesterday s AIDS drug price reduction announcement by British-owned GlaxoSmithKline a hollow gesture that still leaves the life-saving medications out of reach for millions of HIV-infected throughout the world. AIDS Healt
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug. 28, 2002-- Immune Network Ltd. (OTCBB: IMMFF) today announced that it had received a Notice of Allowance from the United States Patent and Trademark Office for each of two patents related to Immune Network s 1F7 technology. Issuance of the patents is expected within a
HOUSTON--(BUSINESS WIRE)--Aug. 20, 2002-- Improper disposal of used hypodermic needles and other sharps outside healthcare facilities poses a potentially serious risk of infection or injury to thousands of Americans, according to the American Medical Association and five other leading public health organizations.
DALLAS--(BUSINESS WIRE)--Aug. 15, 2002--AIDS Arms, Inc., one of the largest Dallas-based private nonprofit agencies providing outpatient medical care, medication assistance and psychosocial services for persons diagnosed with HIV/AIDS, announced today a new program called Free World Bound, which targets HIV+ incarcerat
BERNARDSVILLE, N.J.--(BW HealthWire)--Aug. 15, 2002-- Millennium Biotechnologies, Inc. (OTCBB:MBTG), a wholly owned subsidiary of Millennium Biotechnologies Group, Inc., today announced the introduction of Prosurgex(TM), a high protein/high calorie modular nutritional meal replacement and supplement available in the U.
MIAMI LAKES, Fla.--(BUSINESS WIRE)--Aug. 13, 2002--World Diagnostics, Inc. (OTCBB:WDGI), www.worlddiagnostics.com, an emerging global provider of medical diagnostic tests and specialized laboratory products for the international marketplace, announced today that it concluded initial sales to the government of
SACRAMENTO, Calif.--(BUSINESS WIRE)--Aug. 8, 2002--AIDS Healthcare Foundation: -- Broad Coalition Builds Supporting Unique Bill to Cut Pharmacy Costs for Life-Threatening Illnesses -- Backers Include: AIDS Healthcare Foundation (AHF), California Congress of Seniors, California Public Interest Research Group (CALPIRG),
LAS VEGAS--(BUSINESS WIRE)--Aug. 8, 2002-- Samaritan Pharmaceuticals Inc. (OTCBB:SPHC) and Samaritan Research Labs, Georgetown University, announced in the first issue of its Bull A Ton newsletter that Anticort(R) for HIV, the most mature part of its pipeline, has promising, early, first blush data from its
WESTPORT, Conn.--(BUSINESS WIRE)--Aug. 6, 2002-- Children in southern Africa are already dying from lack of food resulting from the region s biggest threat of famine in over a decade, and the crisis is getting steadily worse, says Save the Children, a leading child development and relief organization. Irregular rainfal
BERNARDSVILLE, N.J.--(BW HealthWire)--Aug. 5, 2002--Millennium Biotechnologies (OTCBB:MBTG), a wholly owned subsidiary of Millennium Biotechnologies Group, Inc., announced today that over 80 physicians in New Jersey, Connecticut and Nevada are actively writing prescriptions for its proprietary product Resurgex(TM). In
HOUSTON--(BUSINESS WIRE)--Aug. 2, 2002--Researched by Industrialinfo.com (Industrial Information Resources Incorporated; Houston). It is estimated that one in nine women in Africa is infected with HIV/AIDS and that globally there are 14,000 new infections each day. In the face of this threat, the announcement of an agr
WASHINGTON, D.C.--(BUSINESS WIRE)--July 31, 2002--At a hearing today, Stop Prisoner Rape, a non-profit human rights organization, will call on the Senate Judiciary Committee to pass the Prison Rape Reduction Act of 2002, a ground-breaking bill that has attracted an unusual coalition of bipartisan backers. The bill is d
EDMONTON, Alberta--(BW HealthWire)--July 30, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it has signed an agreement with M & A Concepts Ltd. of Lagos, Nigeria , to act as our agent for the VScan(TM) Rapid Diagnostic products. M & A Concepts Ltd. will be responsible
VANCOUVER, British Columbia--(BW HealthWire)--July 29, 2002-- Immune Network Ltd. (OTCBB:IMMFF) announced today that it will enter into a collaborative agreement with AbNovo Inc. to develop Immune Network s monoclonal antibody portfolio. AbNovo is a private company recently incorporated under the Canada
NEW YORK--(BW HealthWire)--July 24, 2002-- Vertibrae today announced that its online medical community HIVresistanceWeb (http://wwwHIVresistanceWeb.com) has published the HIV Drug & Mutation Reference Guide, which is now available for free download from the website onto Palm handheld devices and other PDAs utilizin
ALAMEDA, Calif.--(BW HealthWire)--July 19, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, stated today that it filed with the SEC an amended preliminary proxy statement regarding its 2002 Annual Meeting o
VANCOUVER, BRITISH COLUMBIA--(BW HealthWire)--July 18, 2002-- Immune Network Ltd. (OTCBB: IMMKF) announced today that it has signed a research agreement with ViroLogic, Inc. (NASDAQ: VLGC) to evaluate Immune Network s monoclonal antibody hNM01 for its ability to inhibit HIV replication. Under the agreement, ViroLogic s
BARCELONA, Spain & KINDERHOOK, N.Y.--(BUSINESS WIRE)--July 11, 2002-- American Bio Medica Corporation (NASDAQ: ABMC) and Hema Diagnostic Systems (HDS) today announced the signing of a multiple-year contract manufacturing agreement that will lead to the introduction of a new on-site diagnostic test for HIV-1. Na
DURHAM, N.C. & BARCELONA, Spain--(BUSINESS WIRE)--July 11, 2002-- TherapyEdge(TM), Inc., a leading developer of cutting-edge, point-of-care decision support software for individualized patient care, today announced that the International Association of Physicians in AIDS Care (IAPAC), which represents over 12,000 H
PHILADELPHIA--(BUSINESS WIRE)--July 11, 2002--Hemispherx Biopharma, Inc. Ampligen as an adjunct to HAART decreases HIV RNA levels by 0.50 Log after a median duration of 4.5 months. Hemispherx Biopharma, Inc. (AMEX:HEB), a leading company in the experimental-stage development of immune based therapies primarily addressi
ALAMEDA, Calif.--(BW HealthWire)--July 11, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, said today that Dr. Luc Montagnier, co-discoverer of HIV-1 and HIV-2 and president of the World Foundation for AID
SOUTH JORDAN, Utah--(BW HealthWire)--July 11, 2002--ISIPS, the first international sharps injury prevention group, today announced the addition of eight new members. These new corporate members include: Tyco Healthcare/Kendall, OMI, Horizon Medical Products, Inc., MediSafe-guard Products, Inc., ECM Corporation, Medi-Do
DURHAM, N.C. & BARCELONA, Spain--(BUSINESS WIRE)--July 10, 2002-- TherapyEdge(TM), Inc., a leading developer of cutting-edge, point-of-care decision support software for individualized patient care, today announced that the Federal Government of Nigeria has selected its Web-based decision support technology to adva
STANFORD, Calif.--(BW HealthWire)--July 9, 2002--Two Stanford researchers addressed the challenge of drug resistance in AIDS care and how doctors treat their patients with medication. In the first study, researchers investigated how well doctors can predict which patients are likely to develop resistance to AIDS drugs.
PLEASANTON, Calif.--(BW HealthWire)--July 8, 2002--Roche Molecular Diagnostics (Roche) announced today that Roche is supporting the expanded Multicenter AIDS Cohort Study (MACS) through March 2004 by providing a significant number of AMPLICOR(R) PCR (polymerase chain reaction) based assays for detection and quantificat
ALAMEDA, Calif.--(BW HealthWire)--July 8, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, said that the company will present updated results on its research to develop a rapid urine-based screening test fo
SEOUL, South Korea--(BW HealthWire)--July 8, 2002--South Baylo University (SBU) Research Center, an oriental medical research center located in Southern California, has declared the MERIDIAN II the most efficient and effective medical device for monitoring the recovery progress of its AIDS and Cancer patients. SBU purc
SAN DIEGO--(BW HealthWire)--July 8, 2002--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced additional preliminary data from a Phase II clinical trial conducted in South Africa in HIV-infected patients treated with HE2000, an investigational immune regulating hormone. The data include beneficial effects o
BARCELONA, Spain--(BUSINESS WIRE)--July 8, 2002-- Gilead Sciences , Inc. (Nasdaq:GILD) today reported 48-week results from an ongoing Phase III clinical trial (Study 903) comparing Viread (TM) (tenofovir disoproxil fumarate) in terms of efficacy and safety to
EDMONTON, Alberta--(BW HealthWire)--July 3, 2002--Medical Services International Inc. (NQB Pinksheets:MSITF) is pleased to announce that it has signed an agreement with Consolidated Mercantile Consulting Group S.A.L. (CMCG) to act as Medical Services International Inc. is exclusive distributor of the VScan(TM) Rapid Te
PLEASANTON, Calif.--(BW HealthWire)--July 2, 2002--A two-year research surveillance program has commenced between the International Clinical Virology Centre (ICVC), Buckinghamshire, U.K. and Roche Molecular Diagnostics, entitled the SENTRY Study. The study will examine a diverse range of HIV-1 non-B viruses in the U.K.
SOUTH JORDAN, Utah--(BW HealthWire)--July 2, 2002--It occurs in just a fraction of a second -- first, you are taking a routine blood sample and then the patient moves and the needle slips, sticking the potentially infected needle deep into the base of your thumb. As a result, you could contract HIV and die! This scene
LOS ANGELES--(BUSINESS WIRE)--July 2, 2002--AIDS Project Los Angeles (APLA) will present two posters at the XIV International AIDS Conference in Barcelona, Spain : Predictors of Unprotected Anal Intercourse with Casual Sexual Partners among HIV Positive Men who have Sex with Men in Los Angeles County and Integrating
LOS ANGELES--(BUSINESS WIRE)--July 1, 2002--The largest AIDS organization in the United States today files a federal lawsuit charging British-owned GlaxoSmithKline with anti-trust violations that could break the manufacturer s monopolistic hold on key AIDS drugs in the United States. AIDS Healthcare Foundation (AHF
LOS ANGELES--(BUSINESS WIRE)--July 1, 2002--The largest AIDS organization in the United States today files a federal lawsuit charging British-owned GlaxoSmithKline with anti-trust violations that could break the manufacturer s monopolistic hold on key AIDS drugs in the United States. AIDS Healthcare Foundation (AHF
LA JOLLA, Calif.--(BW HealthWire)--June 25, 2002--Aethlon Medical Inc. (OTCBB:AEMD) announced today that a scientific paper authored by R. H. Tullis, R.P. Duffin, M. Zech, and J. A. Ambrus, Jr., entitled Affinity Hemodialysis for Antiviral Therapy. The Removal of HIV-1 from Cell Culture Supernatants, Plasma, and Blood,
ALAMEDA, Calif.--(BW HealthWire)--June 25, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used with urine samples, announced today that it has signed a worldwide non-exclusive distribution agreement with Adaltis Inc. of Montrea
EDMONTON, Alberta--(BW HealthWire)--June 21, 2002--Medical Services International Inc. (Pinksheets:MSITF) is pleased to announce that it has received written requests to be distributors of the VScan(TM) Rapid Test Kits in eight (8) Countries including five (5) Middle East Countries. In order to become a distributor of
LONDON--(BUSINESS WIRE)--June 19, 2002--Regma Bio Technologies Limited (Regma) (OTCBB:RBTL) is pleased to announce that Dr. Juan Pablo Bifani will lead the recently announced research collaboration with the Institut Pasteur de Lille, in Lille, France . Under the collaborative agreement, Regma will sponsor research at t
VERNON HILLS, Ill.--(BUSINESS WIRE)--June 19, 2002--Immtech International, Inc. (NASDAQ: IMMT), announced that it has selected an independent scientific group to validate, through a full genome test system, the activity of the Company s lead hepatitis C drug candidates for advancement into human trials.
CAMARILLO, Calif.--(BUSINESS WIRE)--June 19, 2002--PanaMed Corporation (OTCBB:PANA) announced today it has initiated a limited treatment program in a single West African nation using Viro-Net, a therapeutic with potential for treating HIV/AIDS and related health conditions in third world countries. Viro-Net, supplied e
FOSTER CITY, Calif.--(BUSINESS WIRE)--June 18, 2002-- Gilead Sciences (Nasdaq:GILD) today announced the acceptance of two late breaker presentations at the 14th International AIDS Conference taking place in Barcelona, Spain , from July 7-12, 2002. The presentations include data from a 48-week analysis of the company s
EDMONTON, Alberta--(BW HealthWire)--June 14, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it has started shipping VScan(TM) Rapid Test Kits for Tuberculosis (TB) to various countries for independent verification of the Company s own comprehensive test results. These test res
EDMONTON, Alberta--(BW HealthWire)--June 12, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it now has contracts to supply over 1,300,000 VScan(TM) Rapid Test Kits in the next year. It is projected that these contracts will generate a minimum of $3,120,000 U.S.D. in revenue to
SAN DIEGO--(BW HealthWire)--June 11, 2002--Biokeys Pharmaceuticals Inc. (OTCBB:BKYS) announced today that the Company s Common Shares have been accepted for quotation on the NASD Over the Counter Bulletin Board under the trading symbol BKYS. Biokeys Pharmaceuticals Inc. is a biopharmaceutical research and development c
ALAMEDA, Calif.--(BW HealthWire)--June 11, 2002--Calypte Biomedical Corporation (OTCBB:CALY) announced today that it has executed an agreement with Marukin Diagnostics, Inc. of Berkeley, California for the distribution of Marukin s urinary bile acid sulfate (UBAS) assay. Bile acid levels in urine are a useful marker of
PHILADELPHIA--(BUSINESS WIRE)--June 10, 2002--Hemispherx Biopharma, Inc. (AMEX: HEB), a leading company in the experimental-stage development of immune based therapies primarily addressing the diseases of HIV/AIDS and Chronic Fatigue Syndrome, announced today the receipt of a major new patent on a set of orally active
SEATTLE--(BW HealthWire)--June 7, 2002-- InNexus Corporation, a monoclonal antibody-development company, announced today that it has entered into an agreement to acquire the right to develop the anti-idiotypic, monoclonal antibody 1F7 from Immune Network Ltd., Vancouver, BC, Canada (OTCBB:IMMKF), using SuperAntibody T
The California Pharmacists Association (CPhA) and a coalition of health care advocates urge California legislators to pass SB 1785 (Vasconcellos), the Pharmacy Syringe Sale and Disease Prevention Act. SB 1785 will allow California pharmacists to sell up to 30 syringes without a prescription to adults 18 years and older
ALAMEDA, Calif.--(BW HealthWire)--June 5, 2002--Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, today announced that the company has resumed production of both its EIA Screening and Western Blot Confirmation tes
PHILADELPHIA--(BUSINESS WIRE)--June 5, 2002--Hemispherx Biopharma, Inc. (AMEX: HEB), a leading company in the experimental-stage development of immune based therapies primarily addressing the diseases of HIV/AIDS and Chronic Fatigue Syndrome, announced today that its wholly owned subsidiary, Hemispherx Biopharma Europe
ALAMEDA, Calif.--(BW HealthWire)--May 24, 2002-- Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, today announced the completion of $2.7 million in financing, including $2.125 million in new funding by a private
SEATTLE--(BW HealthWire)--May 22, 2002--Xcyte Therapies, Inc. announced today that it has obtained an exclusive license from the Trustees of the University of Pennsylvania for all human therapeutic rights related to a genetically-modified cell line that can be used to activate and grow T cells. T cells are key componen
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 21, 2002-- Gilead Sciences , Inc. today announced the initiation of a collaborative Phase I clinical trial to evaluate the safety and acceptability of the experimental topical gel formulation of the antiviral tenofovir as a potential prevention method for vaginal transmission o
FOSTER CITY, Calif.--(BW HealthWire)--May 7, 2002-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced preliminary data from a 48-week analysis of the company s ongoing Phase III clinical trial (Study 903) of Viread (TM) (tenofovir disoproxil fumarate). This study was designed to compare the efficacy
PLEASANTON, Calif.--(BW HealthWire)--April 30, 2002--Following 510(k) clearance from the U.S. Food and Drug Administration ( FDA ) earlier this year, Roche Molecular Diagnostics is pleased to announce that its next generation automated PCR system, the COBAS TaqMan(TM) Analyzer, is now commercially available and has alr
(BUSINESS WIRE)-- The HIV/AIDS statistics among youth are staggering. YouthAIDS is addressing this epidemic through a new PSA campaign, produced by Artists Against AIDS Worldwide. This compilation of four PSAs features some of today s most influential young artists speaking freely and openly to kids in their own langua
EDMONTON, Alberta--(BW HealthWire)--April 30, 2002--Mr. Warren Jackson, President and CEO of Altachem Pharma Ltd. is extremely pleased to announce a major achievement in the Company s drug development division with ACP-HIP approaching the end of pre-clinical testing. Results of pre-clinical studies were presented on Ap
FOSTER CITY, Calif.--(BUSINESS WIRE)--April 29, 2002-- Gilead Sciences , Inc. and GlaxoSmithKline today announced the signing of a licensing agreement for the rights to commercialize adefovir dipivoxil, Gilead s investigational antiviral for the treatment of chronic
NEWARK, N.J.--(BUSINESS WIRE)--April 25, 2002--Prudential Financial, Inc. has announced new underwriting guidelines that liberalize the impaired risk ratings for Prostate Cancer, Hepatitis B and Hepatitis C. The new rules apply to all life insurance policies issued by Pruco Life Insurance Company and Pruco Life Insuran
PHILADELPHIA--(BUSINESS WIRE)--April 18, 2002-- Hemispherx Biopharma, Inc. (AMEX: HEB), a leading company in the experimental-stage development of immune based therapies primarily addressing the diseases of HIV AIDS and Chronic Fatigue Syndrome, and the AIDS Community Research Initiative of America, (ACRIA), a leading
NORTH MIAMI, Fla.--(BW HealthWire)--April 17, 2002--Hep-C ALERT founder Andi Thomas recently told a Newsweek Magazine reporter that too few people understand the facts about hepatitis C . This week, the national magazine featured hepatitis C as its cover story, raising concern about this emerging killer.
EDMONTON, Alberta--(BUSINESS WIRE)--April 2, 2002--Medical Services International Inc. (Pink Sheets:MSITF) is pleased to announce that it has signed an agreement with a healthcare corporation based in the United States to supply them with a minimum of 500,000 VScan(TM) HIV rapid test kits to be used in various location
NASHVILLE, Tenn.--(BW SportsWire)--March 20, 2002--Big stars will take to the big Percy Priest Lake on April 30 for the 2nd Annual Fishing For A Cure to benefit the T.J. Martell Foundation for Leukemia, Cancer and AIDS Research. Co-hosted by NFL defensive tackle Jason Fisk and Tennessee Titan Randall Godfrey, the exclu
PRAGUE, Czech Republic--(BUSINESS WIRE)--March 18, 2002--At the 15th International Conference on Antiviral Research held today in Prague, representatives of Hemispherx Biopharma (AMEX:HEB) and Vanderbilt University, Nashville, TN, presented new clinical data on Ampligen(R), an experimental immunotherapeutic designed to
ALAMEDA, Calif.--(BW HealthWire)--March 13, 2002--Calypte Biomedical Corporation (OTCBB:CALY), a public healthcare company dedicated to the development and commercialization of urine-based diagnostic products and services, today announced that in a recently completed Brazilian study Calypte s HIV-1 Urine EIA achieved 1
(BUSINESS WIRE)--Heifer International will host Dr. Japheth K. Mati M.D., director of the Institute for Reproductive Health in Nairobi. He is a former Rockefeller Foundation visiting scientist and Africa s leading expert on AIDS. While in Little Rock, Dr. Mati will present his studies on AIDS in Africa to the Heifer In
FOSTER CITY, Calif.--(BUSINESS WIRE)--March 12, 2002-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the initiation of an Early Access Program (EAP) to provide its investigational agent adefovir dipivoxil 10 mg to people with chronic hepatitis B virus (HBV) infection resistant to the
CAMARILLO, Calif.--(BW HealthWire)--March 11, 2002--PanaMed Corporation (OTCBB:PANA), a California based bio-tech company, plans to test and distribute a proprietary, cost effective line of immuno-modulating therapeutic compounds for the treatment of HIV/AIDS. Anecdotal human case study trials have shown the therapeuti
MONTREAL--(BUSINESS WIRE)--March 6, 2002--Franc-Or Resources Corporation (TSE: FOR.) is pleased to announce that URRMA Biopharma Inc., the private Montreal-based biotech company into which the Company has invested $3 million to date, has filed a patent on a newly discovered subclass of IgG immunoglobulin with broad dia
LAS VEGAS--(BUSINESS WIRE)--March 4, 2002-- Samaritan Research Laboratories of Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) is pleased to announce it has added three new promising drugs which it is processing through pre-clinical trials. Samaritan Research Laboratories in collaboration with Georgetown University has ch
SEATTLE--(BUSINESS WIRE)--Mar. 1, 2002-- A preliminary analysis of early human data suggests that Merck s HIV-1 gag vaccine candidates for the prevention and treatment of HIV-1 elicit specific antiviral cellular immune responses and are generally well tolerated in the ongoing studies, attendees at the 9th Conference on
ORLANDO, Fla.--(BW HealthWire)--Feb. 27, 2002--The head of the world s biggest AIDS-drug manufacturer yesterday declared that his company will sell its drugs at cost in poor nations, explicitly vowing not to make a profit on those sales. AIDS advocates welcomed the news, but in turn challenged GlaxoSmithKline
PHILADELPHIA--(BUSINESS WIRE)--Feb. 27, 2002--Hemispherx Biopharma, Incorporated (AMEX:HEB) announced today that new clinical data on its lead investigational immunotherapeutic drug candidate, Ampligen(R), will be presented on March 18th, 2002, at the upcoming peer-reviewed 15th International Conference on Antiviral Re
SEATTLE--(BW HealthWire)--Feb. 27, 2002--Structural Bioinformatics, Inc. (SBI), based in San Diego, CA, announced today that a new study presented at the 9th Annual Conference on Retroviruses and Opportunistic Infections unveiled a novel computational method for predicting HIV-1 resistance to protease inhibitor drugs.
9th Conference on Retroviruses and Opportunistic Infections SEATTLE--(BUSINESS WIRE)--Feb. 25, 2002-- Results from Aaron Diamond AIDS Research Center Study Presented at 9th Conference on Retroviruses and Opportunistic Infections Gilead Sciences (Nasdaq:GILD) novel treatment for patients infected with HIV,
NORTH MIAMI, Fla.--(BW HealthWire)--Feb. 25, 2002--Starting today, Hep-C ALERT, a national nonprofit organization, is offering low-cost hepatitis C antibody blood tests to the public - anywhere in the U.S. Hep-C ALERT s first announcement of their national low-cost hepatitis C antibody testing program in March 2000, ca
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 25, 2002-- Gilead Sciences , Inc. (Nasdaq:GILD) today announced the launch of Viread .com, a Web site that provides information about the company s HIV drug Viread(TM) (tenofovir disoproxil fumarate), recently approved by the U.
NUTLEY, N.J. & DURHAM, N.C.--(BW HealthWire)--Feb. 19, 2002-- Results From Two Phase II Trials of T-20, First Investigational HIV Fusion Inhibitor, Among Treatment-Experienced Patients Roche and Trimeris, Inc. today announced 48-week results from two Phase II clinical trials evaluating T-20, the furthest in clinica
CAPE TOWN, South Africa--(BW HealthWire)--Feb. 5, 2002--Thanks to Professor Patrick Bouic, chief immunologist at Stellenbosch University in Cape Town, South Africa, many Africans with HIV are living a better quality of life despite their disease due to a specific combination of plant sterols and sterolins that Prof. Bo
FOSTER CITY, Calif.--(BW HealthWire)--Feb. 7, 2002-- Gilead Sciences , Inc. (Nasdaq: GILD) today announced that the European Medicines Evaluation Agency (EMEA) has granted the Marketing Authorisation for Viread (R) (tenofovir disoproxil fumarate) in all 15 member states of the European Union.
NEW YORK--Council Celebrates 50th Year With Announcement of Its Largest Clinical Trial to Date Testing the Effectiveness of a Powerful New HIV- The Population Council announced today that it plans to begin the clinical trials of its lead candidate microbicide, Carraguard(TM), by the end of 2002. A $20 million grant fro
ALAMEDA, Calif.--(BW HealthWire)--Jan. 30, 2002--Calypte Biomedical Corporation (OTCBB:CALY) announced today that Unilab Corporation, (Nasdaq:ULAB), has successfully completed the California licensing requirements to begin offering Calypte s non-invasive HIV-1 urine antibody tests to clients. Unilab is California s lar
CLEVELAND--(BW HealthWire)--Jan. 24, 2002--Empyrean Bioscience, Inc. announced today that as part of its ongoing review of the status of the Phase III clinical trial in Brazil of GEDA(R) Plus microbicidal contraceptive gel, management has met with Sara Gomez de Ferro, president and chief executive officer, and members
NEW YORK--(BW HealthWire)--Jan. 23, 2002--Enzo Biochem, Inc., a leading biotechnology company specializing in gene identification and gene regulation technologies for diagnostic and therapeutic applications, announced at its annual meeting here today that its Board of Directors has declared a 5% stock dividend on the c
SAN CARLOS, Calif.--(BW HealthWire)--Jan. 23, 2002--NeurogesX, Inc., a neuroscience based specialty pharmaceutical company initially focusing on the development of products for the treatment of pain, today announced it has raised $22.86 million in a Series B round of funding. Leading the round was new investor Walden I
PORTLAND, Ore.--(BW HealthWire)--Jan. 22, 2002--The Hepatitis C Caring Ambassadors Program announced today the Internet release of the first venture of its World Class Brainstorming Team. Hepatitis C: Choices is a patient-centered manual for use by people diagnosed with hepatitis C . The 362
NORTH MIAMI, Fla.--(BUSINESS WIRE)--Jan. 22, 2002--Local nonprofit Hep-C ALERT raises awareness of chronic hepatitis C with the 12-week cable TV program From the Streets to the Specialist. The show will air every Monday 8:00pm, Wednesday 9:00am and Friday 12:00pm, starting February 4, 2002 on Community Channel 36.
LOS ANGELES--(BUSINESS WIRE)--Jan. 16, 2002--Scott Evertz, Director of the Office of National AIDS Policy, will conduct a three-day visit to Los Angeles meeting with HIV/AIDS community providers and public officials. This marks Evertz s first official visit to Los Angeles since his appointment by President Bush as dire
PHILADELPHIA--(BW HealthWire)--Jan. 16, 2002--Hemispherx Biopharma, Inc. (AMEX: HEB) announced the filing of a new invention with U.S. patent office designed to potentially outwit the growing challenge of drug resistant AIDS virus. According to recent reports, the HIV/AIDS virus is now outwitting most of the available
VANCOUVER, B.C.--(BUSINESS WIRE)--Jan. 8, 2002--Immune Network Ltd. (OTCBB:IMMKF)(CDNX:IMM.) announced today the publication of results with its 1F7 antibody in tests designed to find out whether it may be able to improve the response of the immune system to infection. The 1F7 antibody is thought to have specific react
PHILADELPHIA--Company Believes That Experimental Immune Based Therapy May Have Potential To Overcome This Problem Hemispherx Biopharma, Inc. (AMEX: HEB), a leading company in the experimental- stage development of immune based therapies primarily addressing the diseases of HIV AIDS and Chronic Fatigue Syndrome commente
SAN ANTONIO--(BW HealthWire)--Jan. 7, 2002--Esoterix Infectious Disease Center announced today the launch of HCVComplete(sm), the most comprehensive Hepatitis C Virus (HCV) testing program available. HCVComplete offers a flexible platform to provide quick, accurate and insightful information for the diagnosis of Hepati
LOS ANGELES--Jan. 6, 2002--Californians living with HIV scored a major victory today as Governor Gray Davis proposed a new regulation to establish the definition of HIV medical specialists under the Standing Referral law (AB 2168). When written, AB 2168 required managed care companies to provide HIV patients with acces
ALAMEDA, Calif.--(BUSINESS WIRE)--Nov. 13, 2002-- Calypte Biomedical Corporation (OTCBB:CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot supplemental test, today announced its Alameda, Cali
This information is designed to support, not replace, the relationship that exists between you and your doctor.